As of Jul 8, 2025, Kalaris Therapeutics Inc has 57 shares failed to deliver, representing 0.12% of the average daily volume of 46,571 shares. Over the past year, the monthly average FTD is 1,517 shares, with the current level 96% below the historical average, indicating low settlement pressure. The weighted FTD ratio below 1% suggests normal market making activity with adequate liquidity.